{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:51:58Z","timestamp":1761166318725,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jmgm.2014.02.006","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T07:15:52Z","timestamp":1394781352000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["In silico investigation of medicinal spectrum of imidazo-azines from the perspective of multitarget screening against malaria, tuberculosis and Chagas disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnita","family":"Makhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2014.02.006_bib0005","first-page":"1","article-title":"Overview of neglected tropical diseases","volume":"7","author":"de las Heras","year":"2011","journal-title":"Trop. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/jm051060o","article-title":"Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis","volume":"49","author":"Somu","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejmech.2004.02.007","article-title":"Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Study of trypanothione binding site of trypanothione reductase as a target for rational design","volume":"39","author":"Aguirre","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bmc.2008.11.018","article-title":"Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes","volume":"17","author":"Lacerda","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-2952(97)00224-4","article-title":"Antiproliferative effects of imidazo[1,2-alpyrazine derivatives on the dami cell line","volume":"54","author":"Zurbonsen","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bmcl.2005.12.037","article-title":"8-Fluoroimidazo[1,2-a]pyridine: synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor","volume":"16","author":"Humphries","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0040","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/jm9507901","article-title":"Synthesis of acyclo-C-nucleosides in the Imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents","volume":"39","author":"Gueiffier","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0045","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ejmech.2011.02.051","article-title":"Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs","volume":"46","author":"Al-Tel","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0050","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R","article-title":"A new heterocyclic multi-component reaction for the combinatorial synthesis of fused 3-aminoimidazole","volume":"37","author":"Bienym\u00e9","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0055","first-page":"1407","article-title":"A regioselective and high yielding method for formaldehyde inclusion in 3CC Groebke-Blackburn-Bienym\u00e9 reaction: one step access to 3-aminoimidazoazines","volume":"10","author":"Sharma","year":"2011","journal-title":"Synlett"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.actatropica.2005.04.002","article-title":"Exploring the folate pathway in Plasmodium falciparum","volume":"94","author":"Hyde","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tips.2007.11.007","article-title":"Novel paradigms for drug discovery: computational multitarget screening","volume":"29","author":"Jenwitheesuk","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0070","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/AAC.00124-07","article-title":"Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase","volume":"51","author":"Sharma","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.str.2007.11.014","article-title":"Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design","volume":"16","author":"Merckx","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0006-291X(02)00632-0","article-title":"Molecular model of shikimate kinase from Mycobacterium tuberculosis","volume":"295","author":"de Azevedo","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0085","first-page":"29","article-title":"Snapshots of the Pantothenate synthetase from Mycobacterium tuberculosis along the reaction coordinate","volume":"1","author":"Wang","year":"2005","journal-title":"Etter Trans."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0090","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1021\/jm040847w","article-title":"Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase","volume":"47","author":"Vanheusden","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0095","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1002\/1521-3773(20011001)40:19<3508::AID-ANIE3508>3.0.CO;2-I","article-title":"Carbohydrate-based antibiotics: a new approach to tackling the problem of resistance","volume":"40","author":"Ritter","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","article-title":"Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors","volume":"7","author":"Bond","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1021\/ci700453j","article-title":"Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies","volume":"48","author":"Guido","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bmcl.2008.12.065","article-title":"Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening","volume":"19","author":"Neres","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0115","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nsb921","article-title":"Insights into antifolate resistance from malarial DHFR-TS structures","volume":"10","author":"Yuvaniyama","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0125","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.M112000200","article-title":"Structural elucidation of the specificity of the antibacterial agent triclosan for malarial triclosan for malarial enoyl acyl carrier protein reductase","volume":"277","author":"Perozzo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1107\/S1744309106046823","article-title":"Structure of shikimate kinase from Mycobacterium tuberculosis complexed with ADP and shikimate at 1.9\u00c5 of resolution","volume":"63","author":"Dias","year":"2007","journal-title":"Acta Crystallogr. Sect. F"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1110\/ps.0241803","article-title":"Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate","volume":"12","author":"Wang","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/jmbi.2001.4843","article-title":"X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95\u00c5 resolution","volume":"311","author":"Li de la Sierra","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tube.2009.10.007","article-title":"ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation","volume":"90","author":"Basavannacharya","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0150","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1046\/j.1432-1033.2003.03857.x","article-title":"Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-d-glyceric acid","volume":"270","author":"Ladame","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.str.2004.02.036","article-title":"Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase","volume":"12","author":"Amaya","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0160","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0165","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"year":"2012","series-title":"User guide AutoDock version 4.2","author":"Morris","key":"10.1016\/j.jmgm.2014.02.006_bib0170"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3724\/SP.J.1009.2010.00051","article-title":"Screening of HMG-CoA reductase inhibitors from composite salvia miltiorrhiza using Autodock","volume":"8","author":"Wei","year":"2010","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0180","first-page":"122","article-title":"Towards antituberculosis drugs: virtual screening for potential inhibitors of pantothenate synthetase of Mycobacterium tuberculosis","volume":"5","author":"Uy","year":"2012","journal-title":"Philipp. Sci. Lett."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bmcl.2009.11.015","article-title":"Towards development of selective and reversible pyrazoline based MAO-inhibitors: synthesis, biological evaluation and docking studies","volume":"20","author":"Sahoo","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0195","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1359-6446(05)03386-6","article-title":"Ligand efficiency indices as guideposts for drug discovery","volume":"10","author":"Abad-zapatero","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2014.02.006_bib0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17460441.2.4.469","article-title":"Ligand efficiency indices for effective drug discovery","volume":"4","author":"Abad-zapatero","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0205","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1021\/ci800242z","article-title":"Design of multi-binding site inhibitors, ligand efficiency and consensus screening of avian influenza H5N1 wild type neuraminidase and of the Oseltamivir-resistance H274Y variant","volume":"10","author":"Garc\u00eda-Sosa","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0210","first-page":"470","article-title":"Molecular properties that influence oral drug \u2013 like behaviour","volume":"7","author":"Lajiness","year":"2004","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.jmgm.2014.02.006_bib0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1359-6446(05)03700-1","article-title":"Improving the hit-to-lead process: data-driven assessment of drug \u2013 like and lead-like screening hits","volume":"11","author":"Wunberg","year":"2006","journal-title":"Drug Discov. Today"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326314000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326314000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:47:50Z","timestamp":1761079670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326314000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":43,"alternative-id":["S1093326314000266"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2014.02.006","relation":{},"ISSN":["1093-3263"],"issn-type":[{"type":"print","value":"1093-3263"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico investigation of medicinal spectrum of imidazo-azines from the perspective of multitarget screening against malaria, tuberculosis and Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2014.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}